Successful Outcome of Low-Dose S-1 Used to Treat Buccal Squamous Cell Carcinoma

This case report describes an 86‐year‐old woman with dormant right buccal squamous cell carcinoma who was able to maintain a reasonable quality of life after being treated with oral low‐dose S‐1 (80 mg/day). The treatment regimen started in April 2014 and consisted of two weeks of S‐1 followed by a one‐week interval. The patient remains on this regimen while maintaining her quality of life and she has been under follow‐up as an outpatient for 36 months. The outcomes for this patient indicated that low‐dose S‐1 is a valid anticancer therapy that may help maintain quality of life for some patients with incurable or dormant cancers.

Abstract licence: CC BY

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.